Latest revenue
$17.8M
as of 2026-03-31
Latest net income
—
as of 2026-03-31
Net margin
—
as of 2026-03-31
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Real Estate Investment Trusts (287 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 7, 2026.
Fair value · DCF
DCF: 10-year forecast of free cash flow, discounted at the company's WACC, with a Gordon-growth terminal at year 10. FCF is proxied by last fiscal-year net income (proper FCF needs CFO − CapEx by year, which we don't store yet). Drag the slider to test your own growth thesis — the dominant assumption in any DCF is what comes next, not what the math does with it. Beta defaults to 1.0 when not reported.
Community sentiment
Where do you think ACR-PD is heading?
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $159.1M
- Enterprise value
- $111.1M
- P/E (trailing)
- 5.7×
- Forward P/E
- —
- P/B
- 0.38×
- Dividend yield
- 6.6%
- 52-wk high
- $22.68
- 52-wk low
- $21.17
- Beta
- —
- Shares out
- 7.1M
5-year trend
What this company does
ITEM 1. BUSINESS General We are a Maryland corporation, incorporated in 2005, and a real estate finance company that is organized and conducts our operations to qualify as a real estate investment trust (“REIT”) for federal income tax purposes under Subchapter M of the Internal Revenue Code of 1986, as amended, or the Code. On February 16, 2021, we amended our certificate of incorporation to change our name to ACRES Commercial Realty Corp. from Exantas Capital Corp. Our investment strategy is primarily focused on originating, holding and managing commercial real estate (“CRE”) mortgage loans and equity investments in commercial real estate property through direct ownership and joint…
AI summary unavailable — showing raw filing excerpt
Generated from ACR-PD's filing dated 2026-03-10
Key risks
ITEM 1A. RISK FACTORS This section describes material risks affecting our business. In connection with the forward-looking statements that appear in this annual report, you should carefully review the factors discussed below and the cautionary statements referred to in “Forward-Looking Statements.” Risk Factors Summary Our risk factors include discussion of risks to our business attributable to the impact of current economic conditions, risks related to our financing, risks related to our operations, risks related to our investments, risks related to our Manager, risks related to our organization and structure, tax risks and general risks, including as follows: •If current economic and…
AI summary unavailable — showing raw filing excerpt
Generated from ACR-PD's filing dated 2026-03-10
Profitability
Net margin
23.5%
28.7%Return on equity
6.6%
1.7%Return on assets
1.3%
15.2%Leverage
Debt / equity
4.14×
26.0%Debt / assets
80.5%
5.1%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $17.8M | +4.8% | — | — | — |
Q4 2025 2025-12-31 | $59.2M | -37.8% | — | — | — |
Q3 2025 2025-09-30 | $21.0M | -5.9% | — | — | — |
Q2 2025 2025-06-30 | $21.9M | +4.5% | — | — | — |
Q1 2025 2025-03-31 | $17.0M | -9.4% | — | — | — |
Q4 2024 2024-12-31 | $95.2M | — | — | — | — |
Q3 2024 2024-09-30 | $22.4M | -6.9% | — | — | — |
Q2 2024 2024-06-30 | $20.9M | -11.4% | — | — | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Real Estate Investment Trusts · SIC 6798
Your notes
Keep private notes on ACR-PD — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for ACR-PD in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns ACR-PD
No institutional holdings on file for ACR-PD yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once ACR-PD's latest filing finishes processing.
Sign in to vote. Votes use 7-day half-life decay.
Sign in to tap. 7-day half-life decay.